Philip J. Ryan
Nessuna posizione attualmente
Profilo
Philip J.
Ryan served as President & Director at Norgenix Pharmaceuticals LLC and as Director at Vascular Pharmaceuticals, Inc. He holds an MBA from Lehigh University and New York University.
Precedenti posizioni note di Philip J. Ryan
Società | Posizione | Fine |
---|---|---|
Norgenix Pharmaceuticals LLC
Norgenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Norgenix Pharmaceuticals LLC is a specialty therapeutics, medical device, and biotech company. It develops, commercializes, and sells pharmaceutical products for women’s health. The company was founded on February 19, 2008 and is headquartered in Spartanburg, SC. | Presidente | - |
Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Direttore/Membro del Consiglio | - |
Formazione di Philip J. Ryan
Lehigh University | Masters Business Admin |
New York University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Norgenix Pharmaceuticals LLC
Norgenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Norgenix Pharmaceuticals LLC is a specialty therapeutics, medical device, and biotech company. It develops, commercializes, and sells pharmaceutical products for women’s health. The company was founded on February 19, 2008 and is headquartered in Spartanburg, SC. | Health Technology |
Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Borsa valori
- Insiders
- Philip J. Ryan